Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma : the multi-country, cross-sectional SABINA III study
Citation
Bateman , E D , Price , D , Wang , H-C , Khattab , A , Schonffeldt , P , Catanzariti , A , van der Valk , R J P & Beekman , M J H I 2022 , ' Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma : the multi-country, cross-sectional SABINA III study ' , European Respiratory Journal , vol. 59 , no. 5 . https://doi.org/10.1183/13993003.01402-2021